Health

Biden Undergoes Radiation and Hormone Therapy for Prostate Cancer

Biden Undergoes Radiation and Hormone Therapy for Prostate Cancer
Editorial
  • PublishedOctober 11, 2025

Former President Joe Biden is currently receiving treatment for an aggressive form of prostate cancer, as confirmed by his spokesperson. The treatment regimen includes both radiation therapy and hormone therapy, aimed at managing his condition effectively.

According to Kelly Scully, a Biden aide, the treatment plan follows a diagnosis made nearly five months ago. In a statement released on Saturday, Scully noted that Biden was diagnosed with prostate cancer characterized by a Gleason score of 9, indicating a more aggressive form of the disease. The Gleason score system is used to grade prostate cancers based on their aggressiveness, with scores ranging from 6 to 10. Scores of 8 to 10 denote particularly aggressive cancers.

The recent treatment decision comes after Biden experienced new symptoms, including increasing urinary issues, prompting further medical evaluation. A prostate nodule was identified, leading to the cancer diagnosis. While the diagnosis raises concerns about his health, Biden’s cancer is reported to be hormone-sensitive, which allows for effective management options.

At 82 years old, Biden is the oldest individual to serve as President of the United States. He left office in January 2023 after opting not to seek reelection, a decision made following a challenging debate against then-candidate Donald Trump. His age and health have been subjects of public interest and concern, particularly in the context of his leadership and the ongoing national discourse regarding the health of political leaders.

This cancer diagnosis adds to Biden’s medical history, which includes a previous diagnosis of skin cancer. His ongoing treatment for prostate cancer reflects a broader conversation about the health challenges faced by aging leaders.

As Biden continues his treatment, the implications for his health and public perception remain significant. The management of his aggressive prostate cancer will be closely monitored as he navigates this personal health challenge.

Editorial
Written By
Editorial

Our Editorial team doesn’t just report the news—we live it. Backed by years of frontline experience, we hunt down the facts, verify them to the letter, and deliver the stories that shape our world. Fueled by integrity and a keen eye for nuance, we tackle politics, culture, and technology with incisive analysis. When the headlines change by the minute, you can count on us to cut through the noise and serve you clarity on a silver platter.